| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0195-5616(88)50132-8 |
| P698 | PubMed publication ID | 3064392 |
| P2093 | author name string | Meric SM | |
| P2860 | cites work | Response to Heparin of Spontaneous Disseminated Intravascular Coagulation in the Dog | Q69376181 |
| A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty | Q70041641 | ||
| The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial | Q70331348 | ||
| Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction | Q70789117 | ||
| Transfusion reactions in cats due to AB blood group incompatibility | Q71083585 | ||
| Use of noninvasive laboratory testing in the prediction of thrombosis in the nephrotic syndrome | Q71380090 | ||
| Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation | Q71507332 | ||
| Aortic embolism in cats: prevalence, surgical treatment and electrocardiography | Q72176482 | ||
| The hypercoagulable states | Q33447844 | ||
| Immune endothelial-cell injury in heparin-associated thrombocytopenia | Q33456857 | ||
| Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial | Q34258431 | ||
| Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis | Q37008397 | ||
| Protective Effect of Cimetidine on Aspirin-Induced Gastric Mucosal Damage | Q39174389 | ||
| Contribution of platelets to thrombus formation | Q39725104 | ||
| Oral anticoagulants in arterial disease | Q39725151 | ||
| Drug interactions with coumarin anticoagulants. 2. | Q39906336 | ||
| Guidelines for heparin therapy | Q39935542 | ||
| Warfarin Therapy | Q39992034 | ||
| Influence of aspirin on platelets and the bleeding time | Q40150501 | ||
| Hypercoagulation and thrombosis | Q40258060 | ||
| The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring | Q41537255 | ||
| Activated coagulation times of whole blood in normal dogs and dogs with coagulopathies | Q42066043 | ||
| Warfarin in the dog: pharmacokinetics as related to clinical response | Q42671393 | ||
| Inhibition of feline collateral vessel development following experimental thrombolic occlusion | Q43615923 | ||
| Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprolol. | Q45901879 | ||
| Low-molecular-weight heparin: is small beautiful? | Q47204187 | ||
| Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. | Q54133467 | ||
| Streptokinase treatment of acute arterial occlusion. | Q54534861 | ||
| Ischaemic neuromyopathy in cats | Q66918106 | ||
| Heparin pharmacokinetics: increased requirements in pulmonary embolism | Q67350817 | ||
| Heparin half-life in normal and impaired renal function | Q68791168 | ||
| Probable vitamin K--deficient bleeding in two cats with malabsorption syndrome secondary to lymphocytic-plasmacytic enteritis | Q68847875 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1217-1241 | |
| P577 | publication date | 1988-11-01 | |
| P1433 | published in | Veterinary Clinics of North America: Small Animal Practice | Q15765188 |
| P1476 | title | Drugs used for disorders of coagulation | |
| P478 | volume | 18 |
| Q37941821 | Laboratory abnormalities in patients with cancer | cites work | P2860 |
Search more.